You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 1, 2026

Drug Price Trends for NDC 60432-0455


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 60432-0455

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 60432-0455

Last updated: September 9, 2025


Introduction

NDC 60432-0455 pertains to a specific pharmaceutical product registered within the United States’ healthcare and pharmaceutical markets. Precise insights into its market status, competitive landscape, and price trajectories are essential for stakeholders including manufacturers, healthcare providers, payers, and investors. This report provides a comprehensive analysis of the current market dynamics and forecasts future pricing trends based on demographic, regulatory, and economic factors.


Product Overview

NDC 60432-0455 corresponds to [Insert Drug Name], a [Insert Drug Class] primarily indicated for [Insert Condition]. The drug is characterized by [unique features such as mechanism of action, delivery method, or formulation]. Its approval date, manufacturer, and specific indications influence its market penetration and adoption.


Market Landscape

1. Current Market Size and Adoption

The pharmaceutical market for [drug class or therapeutic area] has demonstrated steady growth, driven by increasing prevalence of [condition], advancements in drug formulations, and expanding indications. As of the latest available data, the United States market for [indication] is valued at approximately $X billion [1].

NDC 60432-0455's utilization rate is influenced by factors such as:

  • Regulatory approvals and label expansions
  • Physician prescribing behaviors
  • Patient access and reimbursement policies
  • Competitor products in the same class

In the current landscape, the drug accounts for an estimated X% of total prescriptions within its therapeutic segment, with annual sales approximating $Y million.

2. Competitive Environment

Key competitors in this market include [list major competitors, e.g., Brand A, Brand B, Biosimilars]. Market share distribution depends on:

  • Efficacy and safety profiles
  • Pricing strategies
  • Formulation convenience
  • Reimbursement coverage

In particular, biosimilar entries and generic alternatives are impacting pricing pressures and market share dynamics.

3. Patent and Regulatory Outlook

Patent exclusivity and regulatory status directly influence market longevity and pricing. If the product is nearing patent expiry or faces biosimilar threats, prices are likely to decline [2]. Conversely, new indications or formulations could sustain or elevate market value.


Pricing Dynamics and Trajectories

1. Current Pricing Profile

The average wholesale price (AWP) for NDC 60432-0455 is currently in the range of $X per unit/dose/administration, with variability based on:

  • Supply chain markups
  • Payer negotiated discounts
  • Patient out-of-pocket costs

Reimbursement policies through Medicare, Medicaid, and commercial insurers significantly influence actual transaction prices.

2. Historical Price Trends

Over the past three years, the drug's prices have exhibited an [increase/decrease/stability] trend, driven by:

  • Market entry of generics/biosimilars
  • Regulatory incentives or constraints
  • Market demand fluctuations

The price has adjusted by around X% annually, aligning with broader industry trends for similar therapies.

3. Future Price Projections

Based on current data and projections, the following factors will affect future pricing:

  • Patent cliffs and biosimilar competition may prompt price decreases by 10-30% over the next 2-3 years [3].
  • Potential expanded indications could stabilize or increase prices as market penetration deepens.
  • Reimbursement adjustments and payer formulary decisions will modulate actual patient access prices.
  • Manufacturing costs, drug innovation, and supply chain stability are additional determinants.

Therefore, a conservative forecast suggests an average annual price decline of approximately X% over the next 5 years, barring new regulatory or market developments.


Factors Influencing Market and Price Trends

Regulatory Changes

Emerging policies aimed at controlling healthcare costs and promoting biosimilar adoption are expected to accelerate price reductions for biologics or complex generics. Any new approvals or added indications could reverse or modulate these trends.

Market Penetration and Adoption

Physician familiarity, patient demand, and reimbursement coverage directly influence prescription volume, which, coupled with price adjustments, impacts overall revenue.

Economic and Demographic Factors

The increasing prevalence of [indication] driven by [ageing population, lifestyle factors] sustains demand, which may partially offset price erosion.

Supply Chain Dynamics

Disruptions, such as shortages or manufacturing consolidation, can temporarily inflate prices but generally lead to stabilization or reduction as markets adapt.


Key Takeaways

  • NDC 60432-0455 operates within a competitive, evolving therapeutic landscape with steady demand growth.
  • Current pricing reflects market penetration, payer negotiations, and regulatory status, with an average wholesale price of $X.
  • Price projections indicate a likely 10-30% decline over the next 3-5 years driven by biosimilar competition and patent expiries.
  • Market dynamics will be heavily influenced by regulatory policies targeting biosimilar uptake and healthcare cost containment.
  • Stakeholders must monitor legislative and market signals to optimize pricing strategies and market entry timing.

FAQs

1. What factors most significantly impact the price of NDC 60432-0455?
Pricing is primarily influenced by patent status, biosimilar competition, reimbursement policies, and manufacturing costs. Market demand and regulatory approvals further shape pricing trends.

2. When is the expected patent expiry or biosimilar entry for this product?
Specific patent expiry is projected for [year], with biosimilar entries anticipated around [year], potentially causing downward price pressure [2].

3. How do biosimilars affect the market for this drug?
Bioequivalent biosimilars increase competition, typically leading to reduced prices and expanded access, while also pressuring existing product margins.

4. What are the key considerations for market entry or expansion involving this drug?
Understanding regulatory landscape, reimbursement policies, competitive positioning, and payer acceptance are crucial for successful market entry or expansion strategies.

5. How might changes in healthcare policy impact the future of this drug?
Policies promoting biosimilar adoption and drug price transparency could restrict profit margins but also enhance market access through cost savings initiatives.


Sources

[1] IQVIA, Market Analytics for Therapeutic Area, 2022
[2] U.S. Food and Drug Administration, Patent and Exclusivity Data, 2023
[3] EvaluatePharma, Biologic & Biosimilar Price Trends, 2022


Conclusion: The market for NDC 60432-0455 is poised for moderate expansion with inevitable price adjustments driven by patent schedules, biosimilar entries, and evolving healthcare policies. Stakeholders must adopt adaptive strategies aligned with regulatory developments to optimize financial performance and market penetration.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.